These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11010425)

  • 1. Cardiodynamic effects and mechanisms of action of beta-blockers.
    Greenberg BH
    Am J Manag Care; 2000 Apr; 6(6 Suppl):S303-7. PubMed ID: 11010425
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of beta-blockers on morbidity and mortality associated with heart failure.
    Goldstein S
    Am J Manag Care; 2000 Apr; 6(6 Suppl):S308-12. PubMed ID: 11010426
    [No Abstract]   [Full Text] [Related]  

  • 3. Dispelling the myth: incorporating beta-blockers into practice guidelines.
    Packer M
    Am J Manag Care; 2000 Apr; 6(6 Suppl):S313-6. PubMed ID: 11010427
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta-blockers for preventing sudden cardiac death.
    Giles TD; Basile JN
    Postgrad Med; 2003 Dec; 114(6 Suppl Role):30-4. PubMed ID: 19667667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of disease: beta-adrenergic receptors--alterations in signal transduction and pharmacogenomics in heart failure.
    Feldman DS; Carnes CA; Abraham WT; Bristow MR
    Nat Clin Pract Cardiovasc Med; 2005 Sep; 2(9):475-83. PubMed ID: 16265588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta blockers and heart failure.
    Harv Heart Lett; 2004 Oct; 15(2):7. PubMed ID: 15496369
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta-blockers and heart failure.
    Health News; 2000 Apr; 6(4):8. PubMed ID: 15356892
    [No Abstract]   [Full Text] [Related]  

  • 8. [Beta-blockers and cardiac insufficiency: a cultural revolution?].
    Komajda M
    Arch Mal Coeur Vaiss; 1998 Dec; 91(12):1449-51. PubMed ID: 9891826
    [No Abstract]   [Full Text] [Related]  

  • 9. Expert consensus document on beta-adrenergic receptor blockers.
    López-Sendón J; Swedberg K; McMurray J; Tamargo J; Maggioni AP; Dargie H; Tendera M; Waagstein F; Kjekshus J; Lechat P; Torp-Pedersen C;
    Eur Heart J; 2004 Aug; 25(15):1341-62. PubMed ID: 15288162
    [No Abstract]   [Full Text] [Related]  

  • 10. The place for beta-blockers in treating hypertension.
    Kaplan NM
    Eur Heart J; 1999 Jan; 20(1):5-6. PubMed ID: 10075135
    [No Abstract]   [Full Text] [Related]  

  • 11. Protocol Underemphasizes beta-blockers.
    Chase SL
    J Am Pharm Assoc (Wash); 2001; 41(6):793-4. PubMed ID: 11765101
    [No Abstract]   [Full Text] [Related]  

  • 12. Mode of death in patients with systolic heart failure.
    Patel J; Heywood JT
    J Cardiovasc Pharmacol Ther; 2007 Jun; 12(2):127-36. PubMed ID: 17562783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta(3)-Adrenoceptor antagonism improves clinical outcomes of chronic heart failure.
    Wu T; Wang L
    Med Hypotheses; 2007; 69(5):1114-6. PubMed ID: 17428618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta blockers and the failing heart: is it time for a U-turn?
    Bashir Y; McKenna WJ; Camm AJ
    Br Heart J; 1993 Jul; 70(1):8-12. PubMed ID: 7913613
    [No Abstract]   [Full Text] [Related]  

  • 15. Beyond beta blockers.
    Bers DM
    Nat Med; 2005 Apr; 11(4):379-80. PubMed ID: 15812516
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of sudden cardiac death.
    Goldberger JJ
    Heart Dis; 2000; 2(4):305-13. PubMed ID: 11728274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebivolol for heart failure in the elderly.
    Tavazzi L
    Expert Rev Cardiovasc Ther; 2007 May; 5(3):423-33. PubMed ID: 17489667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta blockers as cardioprotective agents: Part II--Focus on prevention of sudden cardiac death.
    Goldstein S
    Am J Manag Care; 2002 Jun; 8(9 Suppl):18-24. PubMed ID: 12099324
    [No Abstract]   [Full Text] [Related]  

  • 19. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal pharmacologic and non-pharmacologic management of cardiac transplant candidates: approaches to be considered prior to transplant evaluation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006.
    Jessup M; Banner N; Brozena S; Campana C; Costard-Jäckle A; Dengler T; Hunt S; Metra M; Rahmel A; Renlund D; Ross H; Warner Stevenson L
    J Heart Lung Transplant; 2006 Sep; 25(9):1003-23. PubMed ID: 16962463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.